Mahal Jeetinder Singh
Insider CIK 1882877 · JSPR See Remarks, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| JSPR Jasper Therapeutics, Inc. | A Award deriv | 2026-02-06 | 2026-02-10 | 500,000 | — | $0 | 500,000 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | A Award deriv | 2026-01-02 | 2026-01-05 | 90,000 | — | $0 | 90,000 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | A Award deriv | 2025-06-04 | 2025-06-06 | 90,000 | — | $0 | 90,000 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | A Award deriv | 2025-02-13 | 2025-02-18 | 50,000 | — | $0 | 50,000 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | M Exercise deriv | 2024-12-12 | 2024-12-12 | 900 | — | $0 | 13,772 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | S Sale | 2024-12-12 | 2024-12-12 | 900 | $22.11 | $19.9K | 25,009 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | M Exercise | 2024-12-12 | 2024-12-12 | 900 | $7.10 | $6.4K | 25,909 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | M Exercise deriv | 2024-09-12 | 2024-09-12 | 900 | — | $0 | 14,672 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | M Exercise | 2024-09-12 | 2024-09-12 | 900 | $7.10 | $6.4K | 25,909 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | S Sale | 2024-09-12 | 2024-09-12 | 900 | $21.23 | $19.1K | 25,009 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | M Exercise deriv | 2024-06-12 | 2024-06-12 | 900 | — | $0 | 15,572 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | M Exercise | 2024-06-12 | 2024-06-12 | 900 | $7.10 | $6.4K | 25,909 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | S Sale | 2024-06-12 | 2024-06-12 | 900 | $24.16 | $21.7K | 25,009 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | M Exercise deriv | 2024-03-12 | 2024-03-12 | 900 | — | $0 | 16,472 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | M Exercise | 2024-03-12 | 2024-03-12 | 900 | $7.10 | $6.4K | 25,909 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | S Sale | 2024-03-12 | 2024-03-12 | 900 | $26.44 | $23.8K | 25,009 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | A Award deriv | 2024-02-15 | 2024-02-20 | 40,000 | — | $0 | 40,000 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | F Tax w/h | 2023-10-12 | 2023-10-13 | 37,126 | $0.85 | $31.6K | 250,097 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | M Exercise deriv | 2023-06-13 | 2023-06-13 | 9,000 | — | $0 | 173,713 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | M Exercise | 2023-06-13 | 2023-06-13 | 9,000 | $0.71 | $6.4K | 296,223 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | S Sale | 2023-06-13 | 2023-06-13 | 9,000 | $1.66 | $14.9K | 287,223 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | F Tax w/h | 2023-04-12 | 2023-04-14 | 37,126 | $1.46 | $54.2K | 287,223 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | A Award deriv | 2023-03-17 | 2023-03-20 | 350,000 | — | $0 | 350,000 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | A Award | 2022-10-12 | 2022-10-13 | 214,722 | — | $0 | 324,349 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | A Award deriv | 2022-04-07 | 2022-04-08 | 48,441 | — | $0 | 48,441 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | A Award deriv | 2022-03-21 | 2022-03-23 | 7,500 | — | $0 | 7,500 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | A Award deriv | 2022-03-21 | 2022-03-23 | 87,272 | — | $0 | 87,272 | SEC↗ |